Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SPHK2 | Q9NRA0 | 12/20 | 0.97 |
| ▸ | SPHK1 | Q9NYA1 | 12/20 | 0.97 |
| ▸ | MAPT | P10636 | 4/20 | 0.97 |
| ▸ | MEN1 | O00255 | 3/20 | 0.97 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.97 |
| ▸ | CETP | P11597 | 3/20 | 0.97 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.97 |
| ▸ | CYP2D6 | P10635 | 3/20 | 0.97 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.97 |
| ▸ | GMNN | O75496 | 2/20 | 0.97 |
| ▸ | LMNA | P02545 | 2/20 | 0.97 |
| ▸ | GLA | P06280 | 2/20 | 0.97 |
| ▸ | POLB | P06746 | 2/20 | 0.97 |
| ▸ | THRB | P10828 | 2/20 | 0.97 |
| ▸ | CXCR5 | P32302 | 2/20 | 0.97 |
| ▸ | CCR6 | P51684 | 2/20 | 0.97 |
| ▸ | BLM | P54132 | 2/20 | 0.97 |
| ▸ | UBE2N | P61088 | 2/20 | 0.97 |
| ▸ | TP53 | P04637 | 2/20 | 0.97 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.97 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Sphingosine SCHEMBL195875 | 1.00 | SPHK2 (0.97) | SPHK2SPHK1MAPTMEN1KMT2A | |
| Sphingosine SCHEMBL27975296 | 1.00 | SPHK2 (0.97) | SPHK2SPHK1MAPTMEN1KMT2A | |
| Sphingosine SCHEMBL2306197 | 0.98 | SPHK2 (1.00) | SPHK2SPHK1MAPTMEN1KMT2A | |
| SCHEMBL21428474 | 0.98 | SPHK2 (1.00) | SPHK2SPHK1MAPTMEN1KMT2A | |
| Sphingosine SCHEMBL6348073 | 0.98 | SPHK2 (1.00) | SPHK2SPHK1MAPTMEN1KMT2A | |
| SCHEMBL22986939 | 0.98 | SPHK2 (1.00) | SPHK2SPHK1MAPTMEN1KMT2A | |
| Sphingosine SCHEMBL22911044 | 0.98 | SPHK2 (1.00) | SPHK2SPHK1MAPTMEN1KMT2A | |
| Sphingosine SCHEMBL21114357 | 0.98 | SPHK2 (1.00) | SPHK2SPHK1MAPTMEN1KMT2A | |
| SCHEMBL21428477 | 0.98 | SPHK2 (1.00) | SPHK2SPHK1MAPTMEN1KMT2A | |
| SCHEMBL22986843 | 0.98 | SPHK2 (1.00) | SPHK2SPHK1MAPTMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 602 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3874959-B1 | NUTRITIONAL COMPOSITION FOR USE IN IMPROVING COGNITIVE PERFORMANCE AND/OR PREVENTING COGNITIVE IMPAIRMENT | NUTRICIA NV (NL) | 2024-07-10 | — | — | EP | disclosed |
| WO-2024121222-A1 | INFANT FORMULA FOR IMPROVING COGNITIVE DEVELOPMENT | N.V. NUTRICIA (NL) | 2024-06-13 | — | — | WO | disclosed |
| US-20240180860-A1 | NUTRITIONAL COMPOSITION FOR IMPROVING CELL MEMBRANES | N.V. NUTRICIA (NL) | 2024-06-06 | — | — | US | disclosed |
| US-11981752-B2 | Tumor associated monocyte/macrophage binding peptide and methods of use thereof | Sanford Burnham Prebys Medical Discovery Institute (US) | 2024-05-14 | — | — | US | disclosed |
| US-20240150397-A1 | TARGETED DELIVERY SYSTEM AND METHODS OF USE THEREFOR | Sanford Burnham Prebys Medical Discovery Institute | 2024-05-09 | — | — | US | disclosed |
| EP-3332649-B1 | A METHOD FOR NON-THERAPEUTIC AMELIORATION OF BEHAVIOURAL PERFORMANCE WITH AN INFANT NUTRITION | NUTRICIA NV (NL) | 2024-04-24 | — | — | EP | disclosed |
| EP-4346447-A1 | INFANT FORMULA FOR IMPROVING BODY COMPOSITION DEVELOPMENT | N.V. Nutricia (NL) | 2024-04-10 | — | — | EP | disclosed |
| US-20240075147-A1 | Compositions Having Improved Bioavailability of Therapeutics | TRx Biosciences Limited (GB) | 2024-03-07 | — | — | US | disclosed |
| EP-4312978-A2 | COMPOSITIONS HAVING IMPROVED BIOAVAILABILITY OF THERAPEUTICS | TRX Biosciences Limited (GB) | 2024-02-07 | — | — | EP | disclosed |
| WO-2024013306-A1 | COMPOSITIONS COMPRISING AMAROUCIAXANTHIN A ESTERS AND USES THEREOF | GAT THERAPEUTICS, S.L. (ES) | 2024-01-18 | — | — | WO | disclosed |
| WO-2002032413-A2 | A METHOD TO INCORPORATE N-(4-HYDROXYPHENYL) RETINAMIDE IN LIPOSOMES | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2002-04-25 | — | — | WO | disclosed |
| WO-2002024232-A2 | PEI: DNA VECTOR FORMULATIONS FOR IN VITRO AND IN VIVO GENE DELIVERY | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2002-03-28 | — | — | WO | disclosed |
| WO-2001025255-A2 | NOVEL ZINC FINGER PROTEIN | BAYLOR COLLEGE OF MEDICINE (US) | 2001-04-12 | — | — | WO | disclosed |
| US-6083920-A | TREATING NERVOUS SYSTEM DISORDERS BY ADMINISTERING LYSOCEREBROSIDE OR LYSOSPHINGOMYELIN | AYURCORE, INC. (US) | 2000-07-04 | — | — | US | disclosed |
| EP-0944309-A1 | COMPOSITIONS FOR MODULATING INTRACELLULAR INOSITOL TRISPHOSPHATE CONCENTRATION AND USES THEREOF | Ayurcore, Inc. (US) | 1999-09-29 | — | — | EP | disclosed |
| WO-1997022251-A1 | COMPOSITIONS FOR MODULATING INTRACELLULAR INOSITOL TRISPHOSPHATE CONCENTRATION AND USES THEREOF | AYURCORE, INC. (US) | 1997-06-26 | — | — | WO | disclosed |
| US-4868289-A | INTERFERE WITH BINDING OF VIRUSES AND BACTERIA, USEFUL AGAINST INFECTION AND FOR DIAGNOSIS | SYMBICOM AKTIEBOLAG (SE) | 1989-09-19 | — | — | US | disclosed |
| EP-0208749-B1 | GLYCOSIDIC DERIVATIVES | SYMBICOM AB (SE) | 1989-04-26 | — | — | EP | disclosed |
| EP-0208749-A1 | GLYCOSIDIC DERIVATIVES. | SYNTEK AB (SE) | 1987-01-21 | — | — | EP | disclosed |
| WO-1986004065-A1 | GLYCOSIDIC DERIVATIVES | SYN-TEK AB (SE) | 1986-07-17 | — | — | WO | disclosed |